Bio-Techne (TECH) EBITDA Margin (2009 - 2026)
Bio-Techne (TECH) recorded quarterly EBITDA Margin of 14.94% in Q1 2026, up 10.37% quarter-over-quarter from 13.54% in Q4 2025, and up 666.0% on a YoY basis from 1.95% in Q1 2025.
Bio-Techne (TECH) EBITDA Margin (2009 - 2026) Analysis & Trends
Bio-Techne's EBITDA Margin history runs 18 years deep, the most recent figure standing at 14.94% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 666.0% year-over-year to 14.94%; the TTM figure through Mar 2026 stood at 10.3% (down 3.0% YoY), while the FY2025 annual figure was 7.53%, down 592.0% from the prior year.
- EBITDA Margin was 14.94% for Q1 2026 at Bio-Techne, up from 13.54% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 3647.25% in Q3 2022 to a low of 1.42% in Q2 2025.
- Historically, EBITDA Margin has averaged 228.56% across 5 years, with a median of 14.39% in 2022.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin jumped 362293 bps in 2022, then tumbled 363315 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 24.56% in 2022, then tumbled by 38 bps to 15.34% in 2023, then plunged by 80 bps to 3.14% in 2024, then soared by 331 bps to 13.54% in 2025, then increased by 10 bps to 14.94% in 2026.
- The last three EBITDA Margin figures came in at 14.94% (Q1 2026), 13.54% (Q4 2025), and 11.75% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 14.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94% |
| Dec 31, 2025 | 13.54% |
| Sep 30, 2025 | 11.75% |
| Jun 30, 2025 | 1.42% |
| Mar 31, 2025 | 8.28% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | 17.91% |
| Jun 30, 2024 | 12.28% |
| Mar 31, 2024 | 12.33% |
| Dec 31, 2023 | 15.34% |
| Sep 30, 2023 | 14.10% |
| Jun 30, 2023 | 27.54% |
| Mar 31, 2023 | 24.41% |
| Dec 31, 2022 | 24.56% |
| Sep 30, 2022 | 3,647.25% |
| Jun 30, 2022 | 14.39% |
| Mar 31, 2022 | 22.41% |
| Dec 31, 2021 | 31.53% |
| Sep 30, 2021 | 24.32% |
| Jun 30, 2021 | 8.37% |